| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Models, Statistical | 49 | 2026 | 598 | 10.950 |
Why?
|
| Exercise | 44 | 2026 | 373 | 7.800 |
Why?
|
| Ecological Momentary Assessment | 24 | 2026 | 55 | 7.510 |
Why?
|
| Smoking | 53 | 2026 | 669 | 6.330 |
Why?
|
| Tobacco Use Disorder | 33 | 2026 | 129 | 5.060 |
Why?
|
| Longitudinal Studies | 72 | 2026 | 1235 | 4.690 |
Why?
|
| Data Interpretation, Statistical | 26 | 2026 | 312 | 4.080 |
Why?
|
| Accelerometry | 14 | 2025 | 49 | 3.710 |
Why?
|
| Smoking Cessation | 34 | 2025 | 302 | 3.180 |
Why?
|
| Motor Skills | 13 | 2024 | 79 | 3.100 |
Why?
|
| Affect | 26 | 2025 | 407 | 2.970 |
Why?
|
| Physical Fitness | 20 | 2024 | 55 | 2.730 |
Why?
|
| Health Behavior | 21 | 2026 | 198 | 2.640 |
Why?
|
| Cigarette Smoking | 8 | 2025 | 56 | 2.530 |
Why?
|
| Vaping | 6 | 2024 | 55 | 2.020 |
Why?
|
| Electronic Nicotine Delivery Systems | 6 | 2024 | 89 | 2.020 |
Why?
|
| Humans | 285 | 2026 | 96382 | 1.970 |
Why?
|
| Body Mass Index | 23 | 2025 | 837 | 1.870 |
Why?
|
| Male | 187 | 2026 | 46116 | 1.800 |
Why?
|
| Female | 192 | 2026 | 50528 | 1.740 |
Why?
|
| Adolescent | 100 | 2026 | 9948 | 1.700 |
Why?
|
| Regression Analysis | 26 | 2017 | 580 | 1.660 |
Why?
|
| Computer Simulation | 18 | 2026 | 1148 | 1.660 |
Why?
|
| Smoking Prevention | 18 | 2020 | 47 | 1.640 |
Why?
|
| Substance-Related Disorders | 14 | 2025 | 463 | 1.600 |
Why?
|
| Child Development | 9 | 2023 | 169 | 1.500 |
Why?
|
| Bayes Theorem | 8 | 2026 | 415 | 1.480 |
Why?
|
| Tobacco Products | 11 | 2025 | 76 | 1.460 |
Why?
|
| Biostatistics | 5 | 2019 | 21 | 1.450 |
Why?
|
| Research Design | 11 | 2023 | 645 | 1.400 |
Why?
|
| Behavior Therapy | 12 | 2026 | 100 | 1.380 |
Why?
|
| Logistic Models | 18 | 2026 | 1270 | 1.370 |
Why?
|
| Nicotine | 8 | 2022 | 216 | 1.360 |
Why?
|
| Siblings | 11 | 2023 | 110 | 1.350 |
Why?
|
| Obesity | 12 | 2026 | 1044 | 1.290 |
Why?
|
| Weight Loss | 6 | 2024 | 241 | 1.270 |
Why?
|
| Feeding Behavior | 7 | 2026 | 344 | 1.260 |
Why?
|
| Weight Reduction Programs | 4 | 2024 | 14 | 1.250 |
Why?
|
| Biometry | 6 | 2020 | 70 | 1.240 |
Why?
|
| Adult | 110 | 2026 | 28968 | 1.230 |
Why?
|
| Life Style | 9 | 2023 | 189 | 1.200 |
Why?
|
| Diet | 6 | 2026 | 467 | 1.200 |
Why?
|
| Motivation | 15 | 2026 | 334 | 1.160 |
Why?
|
| Child | 47 | 2026 | 7540 | 1.150 |
Why?
|
| Wearable Electronic Devices | 2 | 2025 | 42 | 1.080 |
Why?
|
| Computers, Handheld | 8 | 2015 | 34 | 1.060 |
Why?
|
| Adolescent Behavior | 12 | 2015 | 117 | 1.050 |
Why?
|
| Growth Disorders | 4 | 2021 | 64 | 1.030 |
Why?
|
| Smokers | 8 | 2025 | 61 | 1.020 |
Why?
|
| Linear Models | 11 | 2026 | 422 | 1.020 |
Why?
|
| Mental Health | 5 | 2026 | 209 | 1.020 |
Why?
|
| Telemedicine | 8 | 2025 | 238 | 1.010 |
Why?
|
| Alcohol Drinking | 7 | 2023 | 297 | 0.990 |
Why?
|
| Likelihood Functions | 15 | 2026 | 257 | 0.990 |
Why?
|
| Child, Institutionalized | 1 | 2026 | 2 | 0.980 |
Why?
|
| Randomized Controlled Trials as Topic | 12 | 2026 | 975 | 0.980 |
Why?
|
| Young Adult | 54 | 2026 | 7318 | 0.970 |
Why?
|
| Energy Intake | 2 | 2026 | 99 | 0.970 |
Why?
|
| Self Efficacy | 4 | 2026 | 64 | 0.960 |
Why?
|
| Cluster Analysis | 11 | 2022 | 402 | 0.900 |
Why?
|
| Pleasure | 2 | 2024 | 14 | 0.890 |
Why?
|
| Bias | 7 | 2010 | 138 | 0.880 |
Why?
|
| Pediatric Obesity | 3 | 2024 | 37 | 0.860 |
Why?
|
| Frail Elderly | 2 | 2025 | 96 | 0.850 |
Why?
|
| Personal Satisfaction | 2 | 2024 | 67 | 0.850 |
Why?
|
| Software | 7 | 2020 | 684 | 0.850 |
Why?
|
| Health Promotion | 9 | 2025 | 176 | 0.840 |
Why?
|
| Overweight | 5 | 2025 | 122 | 0.820 |
Why?
|
| Altitude | 5 | 2025 | 50 | 0.800 |
Why?
|
| Portugal | 18 | 2024 | 25 | 0.800 |
Why?
|
| Hand Strength | 6 | 2024 | 57 | 0.790 |
Why?
|
| Patient Compliance | 5 | 2017 | 244 | 0.790 |
Why?
|
| Tryptophan | 4 | 2008 | 106 | 0.790 |
Why?
|
| Walking | 2 | 2025 | 109 | 0.770 |
Why?
|
| Middle Aged | 61 | 2026 | 28794 | 0.750 |
Why?
|
| Sleep | 8 | 2026 | 459 | 0.740 |
Why?
|
| Algorithms | 5 | 2026 | 1974 | 0.740 |
Why?
|
| Memory, Short-Term | 2 | 2016 | 255 | 0.700 |
Why?
|
| Stress, Psychological | 7 | 2026 | 378 | 0.700 |
Why?
|
| Social Class | 6 | 2024 | 153 | 0.690 |
Why?
|
| Suicide | 5 | 2013 | 168 | 0.690 |
Why?
|
| Depression | 13 | 2020 | 592 | 0.690 |
Why?
|
| Multilevel Analysis | 8 | 2024 | 26 | 0.680 |
Why?
|
| Intention | 3 | 2026 | 53 | 0.680 |
Why?
|
| Normal Distribution | 3 | 2018 | 37 | 0.680 |
Why?
|
| Data Collection | 6 | 2022 | 375 | 0.680 |
Why?
|
| Geriatric Assessment | 2 | 2025 | 193 | 0.670 |
Why?
|
| Motor Activity | 7 | 2017 | 328 | 0.630 |
Why?
|
| Marijuana Use | 2 | 2019 | 12 | 0.620 |
Why?
|
| Peru | 11 | 2025 | 28 | 0.620 |
Why?
|
| Schools | 9 | 2024 | 91 | 0.620 |
Why?
|
| Treatment Outcome | 23 | 2024 | 9526 | 0.610 |
Why?
|
| Environment | 1 | 2021 | 231 | 0.600 |
Why?
|
| Retirement | 1 | 2019 | 14 | 0.600 |
Why?
|
| Frailty | 1 | 2021 | 102 | 0.600 |
Why?
|
| Vulnerable Populations | 2 | 2021 | 95 | 0.590 |
Why?
|
| Hip Joint | 1 | 2019 | 57 | 0.590 |
Why?
|
| Aged | 27 | 2026 | 21309 | 0.580 |
Why?
|
| Social Environment | 7 | 2023 | 198 | 0.580 |
Why?
|
| Choice Behavior | 6 | 2025 | 162 | 0.580 |
Why?
|
| Nutrition Surveys | 1 | 2019 | 130 | 0.580 |
Why?
|
| Antidepressive Agents | 9 | 2012 | 114 | 0.570 |
Why?
|
| Smartphone | 3 | 2023 | 52 | 0.570 |
Why?
|
| Behavior, Addictive | 6 | 2019 | 138 | 0.560 |
Why?
|
| Epidemiologic Research Design | 1 | 2018 | 23 | 0.560 |
Why?
|
| Risk-Taking | 4 | 2018 | 159 | 0.560 |
Why?
|
| Fluoxetine | 3 | 2007 | 43 | 0.520 |
Why?
|
| Sex Factors | 14 | 2024 | 1135 | 0.520 |
Why?
|
| Alcoholism | 4 | 2015 | 193 | 0.520 |
Why?
|
| Students | 7 | 2025 | 192 | 0.520 |
Why?
|
| Schizophrenia | 10 | 2005 | 543 | 0.520 |
Why?
|
| Time Factors | 15 | 2026 | 5524 | 0.520 |
Why?
|
| Prenatal Exposure Delayed Effects | 4 | 2021 | 176 | 0.510 |
Why?
|
| Nicotinic Agonists | 3 | 2020 | 74 | 0.510 |
Why?
|
| Surveys and Questionnaires | 19 | 2026 | 2951 | 0.500 |
Why?
|
| Menthol | 3 | 2025 | 6 | 0.500 |
Why?
|
| Psychometrics | 6 | 2020 | 355 | 0.490 |
Why?
|
| Depressive Disorder | 13 | 2014 | 229 | 0.490 |
Why?
|
| Adolescent Development | 4 | 2020 | 27 | 0.490 |
Why?
|
| Clinical Trials as Topic | 7 | 2024 | 1118 | 0.490 |
Why?
|
| Propensity Score | 3 | 2018 | 205 | 0.480 |
Why?
|
| Food Preferences | 4 | 2017 | 28 | 0.480 |
Why?
|
| Risk Reduction Behavior | 3 | 2016 | 101 | 0.450 |
Why?
|
| Tobacco Smoking | 4 | 2021 | 33 | 0.450 |
Why?
|
| Preventive Health Services | 1 | 2015 | 38 | 0.450 |
Why?
|
| International Classification of Diseases | 2 | 2017 | 70 | 0.440 |
Why?
|
| Aged, 80 and over | 10 | 2025 | 7277 | 0.440 |
Why?
|
| Residence Characteristics | 3 | 2024 | 224 | 0.430 |
Why?
|
| Substance Withdrawal Syndrome | 4 | 2016 | 55 | 0.430 |
Why?
|
| Telephone | 2 | 2024 | 43 | 0.430 |
Why?
|
| Child Welfare | 1 | 2014 | 44 | 0.420 |
Why?
|
| Research | 1 | 2015 | 256 | 0.410 |
Why?
|
| Psychological Tests | 2 | 2013 | 89 | 0.410 |
Why?
|
| Ecology | 2 | 2012 | 83 | 0.400 |
Why?
|
| Neuropsychological Tests | 2 | 2017 | 558 | 0.400 |
Why?
|
| Monte Carlo Method | 4 | 2026 | 194 | 0.400 |
Why?
|
| Uncertainty | 1 | 2014 | 79 | 0.400 |
Why?
|
| Postural Balance | 1 | 2013 | 54 | 0.400 |
Why?
|
| Gait | 2 | 2013 | 82 | 0.390 |
Why?
|
| Craving | 4 | 2025 | 28 | 0.390 |
Why?
|
| Child Abuse | 1 | 2014 | 96 | 0.390 |
Why?
|
| Thyroxine | 2 | 2026 | 394 | 0.390 |
Why?
|
| Mindfulness | 3 | 2019 | 28 | 0.390 |
Why?
|
| Hypothyroidism | 2 | 2026 | 284 | 0.380 |
Why?
|
| Chicago | 13 | 2025 | 1488 | 0.380 |
Why?
|
| Vegetables | 5 | 2024 | 50 | 0.380 |
Why?
|
| United States | 20 | 2025 | 7976 | 0.380 |
Why?
|
| Follow-Up Studies | 20 | 2026 | 3969 | 0.370 |
Why?
|
| Cannabis | 2 | 2022 | 40 | 0.360 |
Why?
|
| Leisure Activities | 3 | 2016 | 10 | 0.350 |
Why?
|
| Multivariate Analysis | 7 | 2024 | 1007 | 0.350 |
Why?
|
| Mobile Applications | 5 | 2025 | 80 | 0.350 |
Why?
|
| Poisson Distribution | 2 | 2025 | 48 | 0.340 |
Why?
|
| Anticonvulsants | 1 | 2012 | 128 | 0.340 |
Why?
|
| Social Support | 4 | 2010 | 244 | 0.340 |
Why?
|
| Cardiorespiratory Fitness | 2 | 2024 | 11 | 0.340 |
Why?
|
| Receptors, Nicotinic | 3 | 2018 | 133 | 0.340 |
Why?
|
| Medicaid | 1 | 2014 | 271 | 0.340 |
Why?
|
| Markov Chains | 2 | 2026 | 144 | 0.340 |
Why?
|
| Marijuana Abuse | 3 | 2022 | 32 | 0.330 |
Why?
|
| Child, Preschool | 8 | 2023 | 3905 | 0.330 |
Why?
|
| Risk Factors | 20 | 2021 | 6120 | 0.330 |
Why?
|
| Body Weight | 7 | 2025 | 452 | 0.330 |
Why?
|
| Psychomotor Performance | 1 | 2013 | 504 | 0.320 |
Why?
|
| Age Factors | 14 | 2021 | 1957 | 0.320 |
Why?
|
| Activities of Daily Living | 2 | 2010 | 214 | 0.310 |
Why?
|
| State Government | 1 | 2010 | 26 | 0.310 |
Why?
|
| Spouses | 1 | 2010 | 32 | 0.310 |
Why?
|
| Euphoria | 3 | 2019 | 47 | 0.300 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2022 | 195 | 0.300 |
Why?
|
| Blood Pressure | 6 | 2026 | 900 | 0.300 |
Why?
|
| Models, Psychological | 6 | 2012 | 165 | 0.300 |
Why?
|
| Food-Processing Industry | 2 | 2006 | 3 | 0.300 |
Why?
|
| Cohort Studies | 12 | 2020 | 3157 | 0.300 |
Why?
|
| Reproducibility of Results | 11 | 2024 | 2764 | 0.290 |
Why?
|
| Dust | 2 | 2006 | 26 | 0.290 |
Why?
|
| Double-Blind Method | 10 | 2020 | 1759 | 0.290 |
Why?
|
| Community Health Services | 1 | 2010 | 79 | 0.290 |
Why?
|
| Inhalation Exposure | 2 | 2006 | 35 | 0.290 |
Why?
|
| Sexual Maturation | 4 | 2021 | 33 | 0.280 |
Why?
|
| Cross-Sectional Studies | 10 | 2024 | 1981 | 0.280 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 3 | 2020 | 53 | 0.280 |
Why?
|
| Reward | 4 | 2017 | 221 | 0.280 |
Why?
|
| Feeding and Eating Disorders | 3 | 2026 | 188 | 0.280 |
Why?
|
| Cardiovascular Diseases | 3 | 2026 | 785 | 0.270 |
Why?
|
| Mental Disorders | 5 | 2020 | 477 | 0.270 |
Why?
|
| Food | 1 | 2008 | 93 | 0.270 |
Why?
|
| Self Report | 5 | 2022 | 352 | 0.270 |
Why?
|
| Social Behavior | 5 | 2023 | 315 | 0.270 |
Why?
|
| Television | 5 | 2016 | 28 | 0.270 |
Why?
|
| Occupational Exposure | 2 | 2006 | 95 | 0.270 |
Why?
|
| Waist Circumference | 4 | 2022 | 25 | 0.270 |
Why?
|
| Marijuana Smoking | 2 | 2020 | 31 | 0.260 |
Why?
|
| Observation | 1 | 2007 | 37 | 0.260 |
Why?
|
| Thyrotropin | 2 | 2026 | 318 | 0.260 |
Why?
|
| Skinfold Thickness | 2 | 2025 | 8 | 0.260 |
Why?
|
| Random Allocation | 5 | 2018 | 312 | 0.260 |
Why?
|
| Dextroamphetamine | 2 | 2019 | 108 | 0.260 |
Why?
|
| Hunger | 3 | 2026 | 22 | 0.250 |
Why?
|
| Behavioral Medicine | 1 | 2007 | 5 | 0.250 |
Why?
|
| Cognitive Dysfunction | 2 | 2023 | 204 | 0.250 |
Why?
|
| Patient Dropouts | 1 | 2007 | 33 | 0.250 |
Why?
|
| Bibliometrics | 1 | 2007 | 46 | 0.240 |
Why?
|
| Occupational Health | 2 | 2006 | 41 | 0.240 |
Why?
|
| Registries | 5 | 2021 | 1081 | 0.240 |
Why?
|
| Binomial Distribution | 1 | 2025 | 1 | 0.240 |
Why?
|
| Mentoring | 2 | 2024 | 35 | 0.240 |
Why?
|
| Hyperphagia | 1 | 2026 | 36 | 0.230 |
Why?
|
| Socioeconomic Factors | 6 | 2020 | 652 | 0.230 |
Why?
|
| Numerical Analysis, Computer-Assisted | 1 | 2005 | 33 | 0.230 |
Why?
|
| Cytochrome P-450 CYP2A6 | 2 | 2015 | 9 | 0.230 |
Why?
|
| Models, Theoretical | 5 | 2016 | 500 | 0.230 |
Why?
|
| Mood Disorders | 2 | 2016 | 86 | 0.230 |
Why?
|
| Central Nervous System Stimulants | 2 | 2019 | 240 | 0.220 |
Why?
|
| Mental Health Services | 1 | 2026 | 93 | 0.220 |
Why?
|
| Hormone Replacement Therapy | 1 | 2026 | 97 | 0.220 |
Why?
|
| Child Behavior | 2 | 2017 | 51 | 0.220 |
Why?
|
| Cognition | 2 | 2026 | 654 | 0.220 |
Why?
|
| Adiposity | 1 | 2025 | 77 | 0.220 |
Why?
|
| Prevalence | 9 | 2025 | 1362 | 0.220 |
Why?
|
| Fitness Trackers | 1 | 2024 | 6 | 0.210 |
Why?
|
| Fruit | 4 | 2024 | 81 | 0.210 |
Why?
|
| Vascular Stiffness | 1 | 2024 | 29 | 0.210 |
Why?
|
| Bipolar Disorder | 6 | 2006 | 403 | 0.210 |
Why?
|
| Weight Gain | 1 | 2004 | 131 | 0.200 |
Why?
|
| Nicotine Chewing Gum | 2 | 2020 | 3 | 0.200 |
Why?
|
| Physical Education and Training | 1 | 2023 | 4 | 0.200 |
Why?
|
| Quality of Life | 5 | 2025 | 1869 | 0.200 |
Why?
|
| Tobacco Use | 2 | 2023 | 36 | 0.200 |
Why?
|
| Psychopharmacology | 2 | 2013 | 26 | 0.200 |
Why?
|
| Drinking | 4 | 1997 | 34 | 0.200 |
Why?
|
| Urban Population | 4 | 2018 | 243 | 0.200 |
Why?
|
| Biomedical Research | 2 | 2020 | 456 | 0.190 |
Why?
|
| Anthropometry | 3 | 2018 | 77 | 0.190 |
Why?
|
| Forecasting | 3 | 2019 | 292 | 0.190 |
Why?
|
| Dietary Carbohydrates | 3 | 2008 | 39 | 0.190 |
Why?
|
| Statistics as Topic | 4 | 2017 | 230 | 0.190 |
Why?
|
| Particulate Matter | 1 | 2024 | 128 | 0.190 |
Why?
|
| Early Ambulation | 1 | 2023 | 31 | 0.190 |
Why?
|
| Air Pollution | 1 | 2024 | 109 | 0.190 |
Why?
|
| Air Pollutants | 1 | 2024 | 110 | 0.190 |
Why?
|
| Survival Analysis | 3 | 2021 | 1525 | 0.180 |
Why?
|
| Peer Group | 7 | 2015 | 97 | 0.180 |
Why?
|
| Biomedical Technology | 2 | 2013 | 27 | 0.180 |
Why?
|
| Individuality | 3 | 2020 | 119 | 0.180 |
Why?
|
| Hyponatremia | 3 | 1997 | 31 | 0.180 |
Why?
|
| Analysis of Variance | 5 | 2019 | 889 | 0.180 |
Why?
|
| Personality Assessment | 3 | 1996 | 99 | 0.180 |
Why?
|
| Body Fat Distribution | 2 | 2020 | 13 | 0.180 |
Why?
|
| Imipramine | 3 | 2001 | 16 | 0.180 |
Why?
|
| Body Composition | 2 | 2020 | 87 | 0.180 |
Why?
|
| Motor Skills Disorders | 1 | 2001 | 14 | 0.170 |
Why?
|
| Phenotype | 4 | 2021 | 2602 | 0.170 |
Why?
|
| Environmental Exposure | 1 | 2024 | 367 | 0.170 |
Why?
|
| Multicenter Studies as Topic | 3 | 2005 | 194 | 0.170 |
Why?
|
| Psychiatric Status Rating Scales | 9 | 2018 | 502 | 0.170 |
Why?
|
| Crisis Intervention | 1 | 2021 | 13 | 0.170 |
Why?
|
| Probability | 8 | 2019 | 354 | 0.170 |
Why?
|
| Family Characteristics | 2 | 2020 | 52 | 0.160 |
Why?
|
| Growth | 2 | 2017 | 42 | 0.160 |
Why?
|
| Health Education | 6 | 1999 | 109 | 0.160 |
Why?
|
| Chewing Gum | 1 | 2020 | 4 | 0.160 |
Why?
|
| Hypertension | 1 | 2026 | 763 | 0.160 |
Why?
|
| Poverty Areas | 1 | 2020 | 37 | 0.160 |
Why?
|
| Health Surveys | 3 | 2019 | 251 | 0.160 |
Why?
|
| California | 6 | 2022 | 162 | 0.160 |
Why?
|
| Text Messaging | 2 | 2019 | 35 | 0.160 |
Why?
|
| Social Facilitation | 2 | 1996 | 8 | 0.160 |
Why?
|
| Aspartame | 2 | 1996 | 6 | 0.150 |
Why?
|
| Social Determinants of Health | 1 | 2021 | 124 | 0.150 |
Why?
|
| White Matter | 1 | 2020 | 98 | 0.150 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2021 | 581 | 0.150 |
Why?
|
| Infant, Premature | 1 | 2001 | 297 | 0.150 |
Why?
|
| Social Perception | 2 | 2018 | 93 | 0.150 |
Why?
|
| Racism | 1 | 2021 | 106 | 0.150 |
Why?
|
| Computers | 2 | 2016 | 102 | 0.150 |
Why?
|
| Illinois | 1 | 2021 | 517 | 0.150 |
Why?
|
| Taste | 2 | 2017 | 29 | 0.150 |
Why?
|
| Sunscreening Agents | 1 | 1999 | 10 | 0.140 |
Why?
|
| Phobia, Social | 1 | 2018 | 2 | 0.140 |
Why?
|
| Prospective Studies | 8 | 2022 | 4742 | 0.140 |
Why?
|
| Reminder Systems | 1 | 2018 | 19 | 0.140 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2018 | 23 | 0.140 |
Why?
|
| Health Status Disparities | 1 | 2021 | 232 | 0.140 |
Why?
|
| Paroxetine | 1 | 2018 | 26 | 0.140 |
Why?
|
| Family | 5 | 2016 | 327 | 0.140 |
Why?
|
| Smoking Reduction | 1 | 2018 | 4 | 0.140 |
Why?
|
| Lost to Follow-Up | 1 | 2018 | 16 | 0.140 |
Why?
|
| Oxygen Consumption | 1 | 2019 | 236 | 0.140 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 1999 | 96 | 0.140 |
Why?
|
| Pregnancy Complications | 1 | 2001 | 360 | 0.140 |
Why?
|
| Water-Electrolyte Balance | 2 | 1996 | 70 | 0.140 |
Why?
|
| Emotions | 3 | 2017 | 386 | 0.140 |
Why?
|
| Workplace | 2 | 1997 | 36 | 0.140 |
Why?
|
| BRCA2 Protein | 1 | 2019 | 175 | 0.140 |
Why?
|
| Internet | 1 | 2020 | 352 | 0.140 |
Why?
|
| Medical Overuse | 1 | 2018 | 31 | 0.140 |
Why?
|
| Foot | 2 | 2014 | 56 | 0.140 |
Why?
|
| Psychology, Adolescent | 3 | 2012 | 26 | 0.130 |
Why?
|
| Health Planning Guidelines | 1 | 2017 | 25 | 0.130 |
Why?
|
| BRCA1 Protein | 1 | 2019 | 218 | 0.130 |
Why?
|
| Malpractice | 2 | 1995 | 47 | 0.130 |
Why?
|
| Insurance Claim Review | 2 | 2014 | 50 | 0.130 |
Why?
|
| Metabolic Syndrome | 1 | 2019 | 124 | 0.130 |
Why?
|
| Schizophrenic Psychology | 6 | 1997 | 141 | 0.130 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 2 | 2012 | 226 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 2 | 2018 | 507 | 0.130 |
Why?
|
| Patients' Rooms | 1 | 2017 | 14 | 0.130 |
Why?
|
| Proteomics | 1 | 2019 | 269 | 0.130 |
Why?
|
| Running | 1 | 2017 | 30 | 0.130 |
Why?
|
| Mothers | 1 | 2018 | 145 | 0.130 |
Why?
|
| Interpersonal Relations | 1 | 2018 | 178 | 0.130 |
Why?
|
| Thirst | 2 | 1997 | 19 | 0.130 |
Why?
|
| Neoplasms | 2 | 2025 | 3271 | 0.130 |
Why?
|
| Healthy Lifestyle | 1 | 2017 | 8 | 0.130 |
Why?
|
| Clinical Coding | 1 | 2017 | 23 | 0.130 |
Why?
|
| Somatotypes | 1 | 2016 | 4 | 0.120 |
Why?
|
| Rural Population | 1 | 2018 | 184 | 0.120 |
Why?
|
| Pressure Ulcer | 1 | 2017 | 44 | 0.120 |
Why?
|
| Arousal | 1 | 2017 | 172 | 0.120 |
Why?
|
| Diet Therapy | 1 | 2016 | 19 | 0.120 |
Why?
|
| Amphetamine | 2 | 2017 | 101 | 0.120 |
Why?
|
| Case-Control Studies | 4 | 2021 | 1975 | 0.120 |
Why?
|
| Patient Selection | 1 | 2020 | 714 | 0.120 |
Why?
|
| Cooperative Behavior | 1 | 2017 | 199 | 0.120 |
Why?
|
| Feasibility Studies | 2 | 2016 | 792 | 0.120 |
Why?
|
| Germ-Line Mutation | 1 | 2019 | 390 | 0.120 |
Why?
|
| Oropharynx | 1 | 1996 | 14 | 0.120 |
Why?
|
| Breast Neoplasms | 2 | 2021 | 3221 | 0.120 |
Why?
|
| Patient Handoff | 1 | 2017 | 100 | 0.120 |
Why?
|
| Insurance, Liability | 1 | 1995 | 10 | 0.120 |
Why?
|
| Antipsychotic Agents | 3 | 2005 | 162 | 0.120 |
Why?
|
| Legislation, Medical | 1 | 1995 | 10 | 0.120 |
Why?
|
| Body Weights and Measures | 3 | 2021 | 25 | 0.120 |
Why?
|
| Parents | 3 | 2012 | 315 | 0.120 |
Why?
|
| Psychotic Disorders | 5 | 2006 | 232 | 0.110 |
Why?
|
| Spinal Cord Injuries | 1 | 2017 | 115 | 0.110 |
Why?
|
| Risk Management | 1 | 1995 | 43 | 0.110 |
Why?
|
| Health Status | 1 | 2017 | 382 | 0.110 |
Why?
|
| Hospitalists | 1 | 2017 | 138 | 0.110 |
Why?
|
| Specialization | 1 | 1995 | 69 | 0.110 |
Why?
|
| Pregnancy | 5 | 2021 | 3193 | 0.110 |
Why?
|
| Equinus Deformity | 1 | 2014 | 1 | 0.110 |
Why?
|
| Hemiplegia | 1 | 2014 | 11 | 0.110 |
Why?
|
| Work | 1 | 2014 | 15 | 0.110 |
Why?
|
| Antidepressive Agents, Tricyclic | 2 | 2001 | 20 | 0.110 |
Why?
|
| Exploratory Behavior | 1 | 2015 | 48 | 0.110 |
Why?
|
| Psychology, Social | 1 | 1994 | 8 | 0.110 |
Why?
|
| Self Administration | 3 | 2008 | 77 | 0.110 |
Why?
|
| Specialties, Surgical | 1 | 1995 | 80 | 0.100 |
Why?
|
| Odds Ratio | 6 | 2019 | 723 | 0.100 |
Why?
|
| Transportation | 2 | 2016 | 25 | 0.100 |
Why?
|
| Friends | 1 | 2014 | 20 | 0.100 |
Why?
|
| Adaptation, Psychological | 3 | 2020 | 189 | 0.100 |
Why?
|
| Circumcision, Male | 1 | 2013 | 20 | 0.100 |
Why?
|
| Skin Neoplasms | 1 | 1999 | 627 | 0.100 |
Why?
|
| Hospitals, Psychiatric | 1 | 1993 | 23 | 0.100 |
Why?
|
| Hospitals, Public | 1 | 1993 | 15 | 0.100 |
Why?
|
| Tissue and Organ Procurement | 1 | 2018 | 412 | 0.100 |
Why?
|
| Exercise Test | 1 | 2013 | 157 | 0.090 |
Why?
|
| Technology | 1 | 2013 | 31 | 0.090 |
Why?
|
| Chronic Disease | 4 | 2016 | 970 | 0.090 |
Why?
|
| Risk | 4 | 2012 | 659 | 0.090 |
Why?
|
| Remote Consultation | 1 | 2012 | 15 | 0.090 |
Why?
|
| Severity of Illness Index | 4 | 2007 | 1973 | 0.090 |
Why?
|
| New York City | 1 | 2012 | 74 | 0.090 |
Why?
|
| Colorectal Neoplasms | 1 | 2020 | 1087 | 0.090 |
Why?
|
| Comorbidity | 4 | 2021 | 1027 | 0.090 |
Why?
|
| Dietary Proteins | 2 | 2008 | 31 | 0.090 |
Why?
|
| Body Height | 2 | 2024 | 109 | 0.090 |
Why?
|
| Housing | 2 | 2020 | 51 | 0.090 |
Why?
|
| Anxiety | 3 | 2020 | 358 | 0.090 |
Why?
|
| Heart Transplantation | 1 | 2018 | 855 | 0.090 |
Why?
|
| Medicare Part D | 1 | 2011 | 13 | 0.080 |
Why?
|
| Financing, Personal | 1 | 2011 | 21 | 0.080 |
Why?
|
| Veterans | 2 | 2011 | 118 | 0.080 |
Why?
|
| Aggression | 1 | 2015 | 339 | 0.080 |
Why?
|
| Health Services | 1 | 2011 | 54 | 0.080 |
Why?
|
| History, 20th Century | 1 | 2012 | 318 | 0.080 |
Why?
|
| Prescription Drugs | 1 | 2011 | 42 | 0.080 |
Why?
|
| Public Health | 1 | 2012 | 158 | 0.080 |
Why?
|
| Prostatic Neoplasms | 1 | 2021 | 1793 | 0.080 |
Why?
|
| Brain Neoplasms | 1 | 1996 | 834 | 0.080 |
Why?
|
| Proportional Hazards Models | 3 | 2021 | 906 | 0.080 |
Why?
|
| Executive Function | 2 | 2022 | 110 | 0.080 |
Why?
|
| Brain | 2 | 2020 | 2415 | 0.080 |
Why?
|
| Recurrence | 4 | 2020 | 1235 | 0.080 |
Why?
|
| Personality | 3 | 2021 | 140 | 0.080 |
Why?
|
| Ethanol | 2 | 2023 | 278 | 0.080 |
Why?
|
| Psychology, Clinical | 1 | 2010 | 7 | 0.080 |
Why?
|
| Psychotropic Drugs | 2 | 1997 | 82 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2018 | 2508 | 0.070 |
Why?
|
| Facility Design and Construction | 2 | 2006 | 4 | 0.070 |
Why?
|
| Risk Assessment | 4 | 2017 | 2528 | 0.070 |
Why?
|
| Government Regulation | 1 | 2009 | 49 | 0.070 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 800 | 0.070 |
Why?
|
| Automobile Driving | 1 | 2009 | 36 | 0.070 |
Why?
|
| Length of Stay | 1 | 1993 | 860 | 0.070 |
Why?
|
| Intention to Treat Analysis | 1 | 2009 | 81 | 0.070 |
Why?
|
| Sweetening Agents | 1 | 2008 | 17 | 0.070 |
Why?
|
| Home Care Services | 1 | 2010 | 75 | 0.070 |
Why?
|
| Patient Readmission | 1 | 1993 | 419 | 0.070 |
Why?
|
| Environmental Monitoring | 2 | 2006 | 93 | 0.070 |
Why?
|
| Achievement | 1 | 1988 | 30 | 0.070 |
Why?
|
| Body Image | 2 | 2026 | 87 | 0.070 |
Why?
|
| Accidents, Traffic | 1 | 2009 | 108 | 0.070 |
Why?
|
| Factor Analysis, Statistical | 3 | 2020 | 118 | 0.070 |
Why?
|
| Health | 2 | 2019 | 27 | 0.070 |
Why?
|
| Students, Medical | 2 | 1992 | 446 | 0.060 |
Why?
|
| Glycols | 1 | 1986 | 8 | 0.060 |
Why?
|
| Methoxyhydroxyphenylglycol | 1 | 1986 | 18 | 0.060 |
Why?
|
| Manipulation, Chiropractic | 1 | 2006 | 1 | 0.060 |
Why?
|
| Tobacco, Smokeless | 2 | 1997 | 11 | 0.060 |
Why?
|
| Plants, Toxic | 2 | 1997 | 23 | 0.060 |
Why?
|
| Vasopressins | 2 | 1997 | 49 | 0.060 |
Why?
|
| Biomarkers | 3 | 2019 | 1977 | 0.060 |
Why?
|
| Sodium | 3 | 1997 | 330 | 0.060 |
Why?
|
| Family Health | 1 | 2006 | 156 | 0.060 |
Why?
|
| Adolescent Nutritional Physiological Phenomena | 1 | 2006 | 3 | 0.060 |
Why?
|
| Air Pollutants, Occupational | 1 | 2006 | 6 | 0.060 |
Why?
|
| Amino Acids | 1 | 2007 | 246 | 0.060 |
Why?
|
| Pilot Projects | 2 | 2019 | 962 | 0.060 |
Why?
|
| Self-Control | 1 | 2026 | 14 | 0.060 |
Why?
|
| Meals | 1 | 2026 | 23 | 0.060 |
Why?
|
| Low Back Pain | 1 | 2006 | 60 | 0.060 |
Why?
|
| Exercise Therapy | 1 | 2006 | 96 | 0.060 |
Why?
|
| Program Evaluation | 5 | 2011 | 336 | 0.060 |
Why?
|
| Serotonin | 1 | 2007 | 210 | 0.060 |
Why?
|
| School Health Services | 2 | 1996 | 18 | 0.060 |
Why?
|
| Coronary Disease | 1 | 2007 | 225 | 0.060 |
Why?
|
| Walking Speed | 1 | 2025 | 7 | 0.060 |
Why?
|
| Prognosis | 2 | 2026 | 4041 | 0.060 |
Why?
|
| Walk Test | 1 | 2025 | 34 | 0.060 |
Why?
|
| Flavoring Agents | 1 | 2025 | 11 | 0.060 |
Why?
|
| Dexamethasone | 3 | 1993 | 314 | 0.050 |
Why?
|
| Recreation | 1 | 2024 | 9 | 0.050 |
Why?
|
| Restaurants | 1 | 2024 | 6 | 0.050 |
Why?
|
| Periodicals as Topic | 1 | 2007 | 168 | 0.050 |
Why?
|
| Fast Foods | 1 | 2024 | 5 | 0.050 |
Why?
|
| Polyuria | 2 | 1996 | 7 | 0.050 |
Why?
|
| Affective Symptoms | 2 | 1990 | 59 | 0.050 |
Why?
|
| Wireless Technology | 1 | 2024 | 21 | 0.050 |
Why?
|
| Academic Medical Centers | 2 | 2017 | 408 | 0.050 |
Why?
|
| Nitrogen Dioxide | 1 | 2024 | 19 | 0.050 |
Why?
|
| Universities | 1 | 2025 | 162 | 0.050 |
Why?
|
| HIV Infections | 1 | 2013 | 1001 | 0.050 |
Why?
|
| Hydrocortisone | 4 | 1997 | 305 | 0.050 |
Why?
|
| Evidence-Based Medicine | 1 | 2007 | 464 | 0.050 |
Why?
|
| Reference Values | 1 | 2005 | 610 | 0.050 |
Why?
|
| Twins | 1 | 2004 | 64 | 0.050 |
Why?
|
| Stroke | 1 | 2013 | 1140 | 0.050 |
Why?
|
| Minority Groups | 2 | 2020 | 155 | 0.050 |
Why?
|
| Hotlines | 1 | 2003 | 4 | 0.050 |
Why?
|
| Saliva | 2 | 2015 | 129 | 0.050 |
Why?
|
| Public Assistance | 1 | 2003 | 9 | 0.050 |
Why?
|
| Blood Glucose | 2 | 2019 | 901 | 0.050 |
Why?
|
| Social Welfare | 1 | 2003 | 20 | 0.050 |
Why?
|
| Infant, Newborn | 2 | 2001 | 2481 | 0.050 |
Why?
|
| Erectile Dysfunction | 1 | 2004 | 81 | 0.050 |
Why?
|
| Patient Satisfaction | 1 | 2006 | 509 | 0.050 |
Why?
|
| Infant | 2 | 2001 | 3259 | 0.050 |
Why?
|
| Attention | 1 | 2007 | 426 | 0.050 |
Why?
|
| Incidence | 2 | 2017 | 1741 | 0.050 |
Why?
|
| Phenothiazines | 1 | 2001 | 3 | 0.040 |
Why?
|
| Socialization | 1 | 2021 | 13 | 0.040 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2001 | 49 | 0.040 |
Why?
|
| Movement | 1 | 2023 | 312 | 0.040 |
Why?
|
| Self-Assessment | 1 | 2001 | 45 | 0.040 |
Why?
|
| Community Mental Health Centers | 1 | 2001 | 8 | 0.040 |
Why?
|
| Self Care | 2 | 2011 | 187 | 0.040 |
Why?
|
| Case Management | 1 | 2001 | 29 | 0.040 |
Why?
|
| Counseling | 1 | 2003 | 185 | 0.040 |
Why?
|
| Social Identification | 1 | 2021 | 29 | 0.040 |
Why?
|
| Motivational Interviewing | 1 | 2021 | 23 | 0.040 |
Why?
|
| Disease Progression | 2 | 2016 | 1586 | 0.040 |
Why?
|
| Retrospective Studies | 4 | 2022 | 10719 | 0.040 |
Why?
|
| Predictive Value of Tests | 4 | 2015 | 1759 | 0.040 |
Why?
|
| Psychopathology | 1 | 2020 | 31 | 0.040 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2020 | 77 | 0.040 |
Why?
|
| Impulsive Behavior | 2 | 2022 | 294 | 0.040 |
Why?
|
| Hemodynamics | 1 | 2024 | 741 | 0.040 |
Why?
|
| Alzheimer Disease | 1 | 2005 | 633 | 0.040 |
Why?
|
| Pennsylvania | 1 | 2020 | 107 | 0.040 |
Why?
|
| New England | 1 | 2019 | 10 | 0.040 |
Why?
|
| Self Disclosure | 2 | 2006 | 29 | 0.040 |
Why?
|
| Multifactorial Inheritance | 1 | 2022 | 210 | 0.040 |
Why?
|
| Genotype | 2 | 2015 | 1879 | 0.040 |
Why?
|
| Quality of Health Care | 2 | 2013 | 386 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2007 | 1090 | 0.040 |
Why?
|
| Arginine Vasopressin | 2 | 1997 | 44 | 0.040 |
Why?
|
| Equivalence Trials as Topic | 1 | 2019 | 7 | 0.040 |
Why?
|
| Genetic Markers | 2 | 2013 | 470 | 0.040 |
Why?
|
| Brain Injuries | 1 | 2001 | 141 | 0.040 |
Why?
|
| Geography | 1 | 2020 | 247 | 0.040 |
Why?
|
| Osmolar Concentration | 2 | 1997 | 166 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2021 | 414 | 0.040 |
Why?
|
| Critical Illness | 1 | 2023 | 419 | 0.040 |
Why?
|
| Lung Diseases | 1 | 2001 | 283 | 0.040 |
Why?
|
| Haploinsufficiency | 1 | 2019 | 70 | 0.040 |
Why?
|
| Poverty | 1 | 2021 | 212 | 0.040 |
Why?
|
| Birth Weight | 1 | 2019 | 150 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2023 | 505 | 0.040 |
Why?
|
| Manuals as Topic | 2 | 1997 | 9 | 0.040 |
Why?
|
| Anhedonia | 1 | 2018 | 21 | 0.030 |
Why?
|
| Functional Laterality | 1 | 2019 | 207 | 0.030 |
Why?
|
| Triglycerides | 1 | 2019 | 233 | 0.030 |
Why?
|
| Twin Studies as Topic | 1 | 1998 | 19 | 0.030 |
Why?
|
| Protective Factors | 1 | 2018 | 30 | 0.030 |
Why?
|
| Cholesterol, HDL | 1 | 2019 | 173 | 0.030 |
Why?
|
| Social Adjustment | 2 | 2008 | 46 | 0.030 |
Why?
|
| Creatinine | 2 | 1996 | 303 | 0.030 |
Why?
|
| Public Health Surveillance | 1 | 2017 | 24 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2019 | 1937 | 0.030 |
Why?
|
| Water Intoxication | 1 | 1997 | 3 | 0.030 |
Why?
|
| Causality | 1 | 2017 | 82 | 0.030 |
Why?
|
| Attitude | 2 | 1996 | 131 | 0.030 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2017 | 29 | 0.030 |
Why?
|
| Sucrose | 1 | 2017 | 63 | 0.030 |
Why?
|
| Decision Trees | 1 | 2017 | 63 | 0.030 |
Why?
|
| Iatrogenic Disease | 1 | 2017 | 69 | 0.030 |
Why?
|
| Gene-Environment Interaction | 1 | 2018 | 121 | 0.030 |
Why?
|
| Biogenic Amines | 1 | 1996 | 2 | 0.030 |
Why?
|
| Maternal Deprivation | 1 | 1996 | 8 | 0.030 |
Why?
|
| Combined Modality Therapy | 2 | 2002 | 1738 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 360 | 0.030 |
Why?
|
| Biomechanical Phenomena | 2 | 2014 | 500 | 0.030 |
Why?
|
| Cell Phone | 1 | 2016 | 39 | 0.030 |
Why?
|
| Urea | 1 | 1996 | 54 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1996 | 244 | 0.030 |
Why?
|
| Habits | 1 | 1996 | 17 | 0.030 |
Why?
|
| India | 1 | 2016 | 149 | 0.030 |
Why?
|
| Orthotic Devices | 1 | 1996 | 12 | 0.030 |
Why?
|
| Oregon | 1 | 1995 | 25 | 0.030 |
Why?
|
| Hospitalization | 2 | 2017 | 963 | 0.030 |
Why?
|
| Dietary Fats | 1 | 2016 | 134 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 1996 | 138 | 0.030 |
Why?
|
| Sports | 1 | 2016 | 41 | 0.030 |
Why?
|
| Age of Onset | 2 | 2006 | 354 | 0.030 |
Why?
|
| Urine | 1 | 1996 | 91 | 0.030 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2015 | 45 | 0.030 |
Why?
|
| Sodium Chloride | 1 | 1996 | 93 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2020 | 527 | 0.030 |
Why?
|
| Joint Diseases | 1 | 1996 | 47 | 0.030 |
Why?
|
| Continuity of Patient Care | 1 | 2017 | 176 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2021 | 2055 | 0.030 |
Why?
|
| Social Conformity | 1 | 2015 | 2 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 1 | 2017 | 237 | 0.030 |
Why?
|
| Relaxation Therapy | 1 | 2015 | 4 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2017 | 391 | 0.030 |
Why?
|
| Genetic Linkage | 2 | 2006 | 613 | 0.030 |
Why?
|
| Temperament | 1 | 2015 | 29 | 0.030 |
Why?
|
| Attitude to Health | 2 | 1994 | 217 | 0.030 |
Why?
|
| Headache | 1 | 1995 | 79 | 0.030 |
Why?
|
| Mathematics | 1 | 1994 | 178 | 0.030 |
Why?
|
| Ankle | 1 | 2014 | 21 | 0.030 |
Why?
|
| Seasons | 1 | 2016 | 243 | 0.030 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1995 | 67 | 0.030 |
Why?
|
| Antisocial Personality Disorder | 1 | 2015 | 92 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2014 | 169 | 0.030 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1996 | 185 | 0.030 |
Why?
|
| Mass Media | 1 | 1994 | 26 | 0.030 |
Why?
|
| Cerebral Palsy | 1 | 2014 | 98 | 0.030 |
Why?
|
| Water | 1 | 1996 | 310 | 0.030 |
Why?
|
| Africa South of the Sahara | 1 | 2013 | 26 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 1997 | 406 | 0.030 |
Why?
|
| Brain Mapping | 1 | 2017 | 578 | 0.030 |
Why?
|
| Employment | 1 | 1994 | 62 | 0.020 |
Why?
|
| Human Genome Project | 1 | 2013 | 22 | 0.020 |
Why?
|
| Computer Security | 1 | 2013 | 17 | 0.020 |
Why?
|
| Pain Management | 1 | 1996 | 188 | 0.020 |
Why?
|
| Paresis | 1 | 2013 | 21 | 0.020 |
Why?
|
| Medicare | 1 | 2017 | 463 | 0.020 |
Why?
|
| Adult Children | 1 | 2013 | 13 | 0.020 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 1993 | 18 | 0.020 |
Why?
|
| Feedback, Sensory | 1 | 2013 | 22 | 0.020 |
Why?
|
| Diffusion of Innovation | 1 | 2013 | 80 | 0.020 |
Why?
|
| Maternal Exposure | 1 | 2013 | 63 | 0.020 |
Why?
|
| Arm | 1 | 2013 | 100 | 0.020 |
Why?
|
| Marital Status | 1 | 1993 | 44 | 0.020 |
Why?
|
| Religion and Psychology | 1 | 1992 | 16 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2017 | 412 | 0.020 |
Why?
|
| Cocaine | 1 | 1993 | 80 | 0.020 |
Why?
|
| Personal Autonomy | 1 | 2013 | 125 | 0.020 |
Why?
|
| Clinical Medicine | 1 | 1992 | 26 | 0.020 |
Why?
|
| Pain | 2 | 2011 | 415 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2013 | 407 | 0.020 |
Why?
|
| Nonlinear Dynamics | 1 | 2012 | 68 | 0.020 |
Why?
|
| Fatigue | 1 | 2013 | 185 | 0.020 |
Why?
|
| Oxygen | 1 | 2017 | 782 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2013 | 708 | 0.020 |
Why?
|
| Haplotypes | 1 | 2013 | 652 | 0.020 |
Why?
|
| Parent-Child Relations | 2 | 2006 | 87 | 0.020 |
Why?
|
| Haloperidol | 1 | 1991 | 29 | 0.020 |
Why?
|
| Models, Economic | 1 | 2011 | 62 | 0.020 |
Why?
|
| Drug Utilization | 1 | 2011 | 65 | 0.020 |
Why?
|
| Dangerous Behavior | 1 | 1990 | 6 | 0.020 |
Why?
|
| Hydroxyindoleacetic Acid | 1 | 1990 | 27 | 0.020 |
Why?
|
| Robotics | 1 | 2013 | 270 | 0.020 |
Why?
|
| Pain Measurement | 2 | 2006 | 397 | 0.020 |
Why?
|
| Health Services Research | 1 | 2011 | 144 | 0.020 |
Why?
|
| Curriculum | 1 | 1994 | 615 | 0.020 |
Why?
|
| Anxiety Disorders | 2 | 1990 | 157 | 0.020 |
Why?
|
| Public Policy | 1 | 2009 | 60 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2013 | 510 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 2494 | 0.020 |
Why?
|
| Circadian Rhythm | 2 | 1992 | 287 | 0.020 |
Why?
|
| Personality Inventory | 2 | 1992 | 112 | 0.020 |
Why?
|
| Suicide, Attempted | 2 | 2006 | 143 | 0.020 |
Why?
|
| Quality Control | 1 | 2009 | 125 | 0.020 |
Why?
|
| Violence | 1 | 1990 | 161 | 0.020 |
Why?
|
| DNA | 1 | 2013 | 1270 | 0.020 |
Why?
|
| Acute Disease | 2 | 2001 | 850 | 0.020 |
Why?
|
| Panic Disorder | 1 | 2006 | 21 | 0.020 |
Why?
|
| Amitriptyline | 1 | 1986 | 11 | 0.020 |
Why?
|
| Lod Score | 1 | 2006 | 152 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2006 | 78 | 0.020 |
Why?
|
| Genetic Heterogeneity | 1 | 2006 | 70 | 0.020 |
Why?
|
| Time | 1 | 2006 | 80 | 0.020 |
Why?
|
| Diazepam | 1 | 1986 | 26 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2011 | 515 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2006 | 175 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2006 | 127 | 0.010 |
Why?
|
| Carbonated Beverages | 1 | 2006 | 2 | 0.010 |
Why?
|
| Range of Motion, Articular | 1 | 2006 | 175 | 0.010 |
Why?
|
| Wounds and Injuries | 1 | 2009 | 295 | 0.010 |
Why?
|
| Periodicity | 1 | 2006 | 114 | 0.010 |
Why?
|
| Cues | 1 | 2007 | 191 | 0.010 |
Why?
|
| Models, Biological | 2 | 1991 | 1792 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 3562 | 0.010 |
Why?
|
| Survival Rate | 1 | 2009 | 2019 | 0.010 |
Why?
|
| Pedigree | 1 | 2006 | 971 | 0.010 |
Why?
|
| Appetite | 1 | 1983 | 21 | 0.010 |
Why?
|
| Conditioning, Operant | 1 | 2003 | 68 | 0.010 |
Why?
|
| Diagnosis, Differential | 2 | 1987 | 1549 | 0.010 |
Why?
|
| Animals | 3 | 2017 | 28471 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2006 | 575 | 0.010 |
Why?
|
| Eating | 1 | 2003 | 162 | 0.010 |
Why?
|
| Macaca mulatta | 2 | 1996 | 457 | 0.010 |
Why?
|
| Military Personnel | 1 | 2004 | 117 | 0.010 |
Why?
|
| New Hampshire | 1 | 2001 | 3 | 0.010 |
Why?
|
| Sexual Behavior | 1 | 1983 | 338 | 0.010 |
Why?
|
| Placebos | 2 | 1993 | 207 | 0.010 |
Why?
|
| Vietnam | 1 | 1998 | 16 | 0.010 |
Why?
|
| Dreams | 1 | 1998 | 5 | 0.010 |
Why?
|
| Warfare | 1 | 1998 | 12 | 0.010 |
Why?
|
| Epidemiologic Methods | 1 | 1998 | 60 | 0.010 |
Why?
|
| Inappropriate ADH Syndrome | 1 | 1997 | 5 | 0.010 |
Why?
|
| Methylphenidate | 1 | 1997 | 11 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2001 | 1934 | 0.010 |
Why?
|
| Self-Help Groups | 1 | 1997 | 15 | 0.010 |
Why?
|
| Sampling Studies | 1 | 1997 | 75 | 0.010 |
Why?
|
| Effect Modifier, Epidemiologic | 1 | 1996 | 4 | 0.010 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 1998 | 130 | 0.010 |
Why?
|
| Steroids | 1 | 1996 | 168 | 0.010 |
Why?
|
| Heart Rate | 1 | 1997 | 528 | 0.010 |
Why?
|
| National Institute of Mental Health (U.S.) | 1 | 1993 | 22 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1996 | 252 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1996 | 355 | 0.010 |
Why?
|
| Psychotherapy | 1 | 1993 | 73 | 0.010 |
Why?
|
| Observer Variation | 1 | 1994 | 573 | 0.010 |
Why?
|
| Urodynamics | 1 | 1992 | 127 | 0.010 |
Why?
|
| Electroconvulsive Therapy | 1 | 1992 | 26 | 0.010 |
Why?
|
| Aging | 1 | 1996 | 757 | 0.010 |
Why?
|
| Panic | 1 | 1990 | 3 | 0.010 |
Why?
|
| Social Behavior Disorders | 1 | 1990 | 20 | 0.000 |
Why?
|
| Hippocampus | 1 | 1993 | 462 | 0.000 |
Why?
|
| Personality Disorders | 1 | 1990 | 145 | 0.000 |
Why?
|
| Pituitary-Adrenal System | 1 | 1987 | 69 | 0.000 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 1987 | 83 | 0.000 |
Why?
|